Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se
Patent
1995-06-09
1998-12-15
Degen, Nancy
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Primate cell, per se
435375, 514185, C12N 508
Patent
active
058495878
ABSTRACT:
The present invention is directed to methods which employ inhibition of the post-translational hypusine formation in the intracelluar protein eIF-5A, for the purpose of suppressing infections by viruses that parasitize eIF-5A so as to promote their own replication. Intentional inhibition of the post-translational formation of hypusine in infected host cells with compounds generically termed `hypusine inhibitors` not only selectively suppresses the production of viral proteins and of infectious viral particles, but also causes, particularly after hypusine inhibitor withdrawal, apoptosis in such virally-infected cells. Each of these methods, respectively, involves administering, to eukaryotic cells, tissues, or individuals, an agent which blocks the post-translational intracellular formation of hypusine, in an amount sufficient to: suppress biosynthesis of bioactive eIF-5A, suppress translational interaction of eIF-5A with viral elements of nucleic acid and/or protein structure, inhibit biosynthesis of viral proteins of Rev-dependent lentiviruses or of viruses dependent on interaction of eIF-5A with viral elements of nucleic acid and/or protein structure, inhibit replication of Rev-dependent lentiviruses or of viruses dependent on interaction of eIF-5A with viral elements of nucleic acid and/or protein structure, and induce apoptosis of virally-infected cells. This agent can be a compound of Formulae I or II and derivatives thereof as follows: ##STR1## R.sub.1, R.sub.2, R.sub.3, and R.sub.4 each individually represent a hydrogen, an alkyl, alkenyl, or alkoxy group containing 1 to about 8 carbon atoms, an aryl, aralkyl, or cycloalkyl group containing about 5 to 12 carbon atoms, or a carboalkoxy or carbamyl group containing up to 8 carbon atoms, or a peptide or peptidomimetic moiety containing 10 to about 30 carbon atoms.
REFERENCES:
patent: 4246266 (1981-01-01), Undheim et al.
patent: 4585780 (1986-04-01), Hider et al.
patent: 4840958 (1989-06-01), Hider et al.
patent: 4908371 (1990-03-01), Moerker et al.
patent: 5185352 (1993-02-01), Aranda et al.
patent: 5256676 (1993-10-01), Hider et al.
patent: 5262409 (1993-11-01), Margolis et al.
patent: 5344846 (1994-09-01), Jakus et al.
patent: 5399566 (1995-03-01), Katano et al.
Herahko et al., "Results of Long-Term Deferiprone (LI) Therapy," Blood, (1994) (abstract).
Abbruzzese, A. et al. Biochim. et Biophys. Acta 1991. pp. 159-166.
Mitsuya, H. et al. 1990 Science vol. 249 pp. 1533-1544.
Park, M. H. et al. 1993 Biofactors vol. 4 (2) pp. 95-104.
Hashiguchi, et al., "Inhibition of Two Copper-Containing Enzymes, Tyrosinase and Dopamine .beta.-Hydroxylase, by L-Mimosine," Molecular Pharmacology, 13(2):362-367 (1977).
McCaffrey et al., "Specific Inhibition of eIF-5A and Collagen Hydroxylation by a Single Agent: Antiproliferative and Fibro-suppressive Effects on Smooth Muscle Cells from Human Coronary Arteries," Journal of Clinical Investigation, 95:446-455 (1995).
Andrus Linda
Grady Robert Walter
Hanauske Axel
Hanauske-Abel Hartmut M.
Szabo Paul
Cornell Research Foundation Inc.
Degen Nancy
Yucel Irem
LandOfFree
Method of inhibiting viral replication in eukaryotic cells and o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting viral replication in eukaryotic cells and o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting viral replication in eukaryotic cells and o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1457143